Explore / Clinical trial
Clinical trial

Impact of Fingolimod Adherence on Outcomes

Novartis PharmaceuticalsCompletedStarted May 18, 2020694 enrolledUnited StatesNCT05141669

Abstract

This study was a retrospective observational claims data study of commercial and Medicare Advantage with Part D (MAPD) patients initiating fingolimod.

Keywords

Multiple Sclerosis

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.